The QualityStocks Daily Friday, March 8th, 2019

Today's Top 3 StockMarketWatch

StocksToBuyNow (RGNP) +41.88%

MarketClub Analysis (ALQA) +35.91%

QualityStocks (RCCMF) +33.77%

The QualityStocks Daily Stock List

Q BioMed, Inc. (QBIO)

Insider Financial, Proactive Investors, See Thru Equity Research, Market Screener, Penny Stock Tweets, Super Stock Screener, Business Insider, Tip Ranks, Stock News Now, Investing News, Simply Wall St, StockPicksNYC, and Barchart reported earlier on Q BioMed, Inc. (QBIO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a commercial stage biomedical acceleration and development company. Its dedication is to licensing and acquiring biomedical assets across the healthcare spectrum. The Company’s commitment is to provide these target assets the strategic resources, developmental support, and expansion capital they require to ensure they meet their developmental potential, enabling them to provide products to patients in need. Q BioMed is based in New York, New York.

The Company’s mission is to license and acquire unique life sciences assets from academia or small private companies. Q BioMed has numerous assets across a broad array of healthcare related products, companies, and sectors. These assets will undergo development to provide returns via organic growth or out-licensing, sale, or be spun out into new public companies. Q BioMed is concentrating on clinical stage and innovative products where the technical, regulatory, and commercial risks have been lessened or significant valuation modulations are pending.

The Company has commenced production of Strontium-89 Chloride - a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain. AB-Rated Strontium Chloride Sr89 Injection USP (Sr89) can be utilized in combination with, or to reduce the requirement for opiate based drugs, and also in combination with cancer therapeutic drugs.

Q BioMed also is developing a unique molecule delivered in an easy-to-administer eye drop designed to repair the normal flow of fluid in the eye resulting in the decreasing of IOP (Intraocular Pressure) . The Company, together with its partner, Mannin Research, Inc, is the only company targeting this mechanism of action.

Q BioMed announced in November of 2018 that it entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™, from GE Healthcare. This agreement gives Q BioMed ownership of the brand, trademarks and market authorizations in 22 countries.

Q BioMed announced recently that its technology partner, Mannin Research, initiated a collaboration with McMaster University of Ontario, Canada. This collaboration is centered on ophthalmic drug delivery and formulation experiments for MAN-01, a first-in-class small molecule to treat Primary Open-Angle Glaucoma. Experiments will be conducted Dr. Heather Sheardown, a world renowned thought leader in ophthalmic biomaterials and drug delivery.

Uttroside-B is Q BioMed's liver cancer orphan drug candidate. The Company plans to complete pre-clinical work and prepare IND Proof of Concept Studies in the First Half of 2019 then file an IND in Q3 of 2019.

QBM-001 is the Company’s potential orphan drug treatment for young children and toddlers who are on the autism spectrum and are minimally verbal or non-verbal. Q BioMed is very hopeful that this therapy, consisting of very safe and well-known active ingredients, can make a major difference for these children and families. It looks forward to the completion of formulation and manufacturing by the end of Q2 2019 and a subsequent filing of an IND. The green light will permit it to commence a relatively short pivotal clinical trial of QBM-001 in Q3 2019.

Q BioMed’s commitment is to to growing and expanding the reach of its cancer palliation drugs. Its belief is that Metastron has significant untapped potential in expanded cancer therapeutic indications.

Golden Arrow Resources Corp. (QBIO), closed Friday's trading session at $1.85, up 5.11%, on 47,744 volume with 114 trades. The average volume for the last 3 months is 69,518 and the stock's 52-week low/high is $0.899/$3.95.

chart

Nippon Dragon Resources, Inc. (RCCMF)

OTC Markets Group, InvestorsHub, MarketWatch, Investor Place, Stock Gumshoe, Zacks, Dividend Investor, Morningstar, Talk Markets, Streetwise Reports, 4-Traders, Wallet Investor, GuruFoucs, YCharts, and Stockhouse reported previously on Nippon Dragon Resources, Inc. (RCCMF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Nippon Dragon Resources, Inc. is a hybrid mining & technology enterprise listed on the OTC Markets. The Company has high potential and advanced stage mining assets combined with an innovative and exclusive green mining method. Nippon is active in the exploration and development of gold resources in the Province of Quebec. Nippon’s flagship gold property is Rocmec 1. Nippon Dragon Resources is headquartered in Brossard, Quebec.

The Company has its Thermal Fragmentation mining method. This mining method uses heat to 'spall' high-grade veins. This considerably lessens the use of explosives. The method only extracts the mineralized ore with minimal dilution. The extraction process allows thermal fragmentation with an accuracy of 2 cm to quickly extract any type of hard rock up to 110 cm wide. The thermal unit can be set up to extract a specific corridor. Thermal Fragmentation could be used as a stand-alone method or as a first-rate complement to any conventional hard rock mining operation.

In June of last year, Nippon Dragon Resources announced that following the sale of a Thermal Fragmentation Unit to its client, Metalfer Mining D.O.O, the Unit was shipped, received, inspected by border authorities and released to the client. Nippon’s technical team performed its customary four week orientation, training, and implementation programme of its thermal fragmentation mining method at Metalfer’s mining site in the Majdan Mountain district of Serbia.

Nippon Dragon Resources has a strategic partnership agreement with Val d’Or Resources (VOR). This partnership agreement will enhance Nippon Dragon’s position as an industry leader with its exclusive and patented Thermal Fragmentation technology. Through the creation of a new entity, Rocmec Gold, Inc., the new partnership is anticipated to substantially expand Nippon Dragon’s reach within Canada and other important markets.

Nippon’s flagship Rocmec 1 is a fully permitted project in Quebec. The project includes a 100-meter deep, two-compartment shaft, and an 844 meters decline, allowing access to four levels (50, 90, 110 and 130 meters).

Additionally, Nippon has its Denain Project. This project covers two contiguous mining properties (Venpar and Vauquelin) totaling 24 mining titles. The Denain Project is about 60 km east of Val d'Or, Quebec. At the end of August 2018, Nippon Dragon Resources announced that it signed a joint venture (JV) agreement with a group of private investors to develop its Denain gold property.

In addition, Nippon has its Courville-Maruska exploration property in Courville Township, roughly 32 kilometers’ northeast of Val-d'Or, Quebec. The property consists of 20 mining claims covering an area of around 800 hectares. The property is on a gold-bearing quartz vein system.

Nippon Dragon Resources, Inc. (RCCMF), closed Friday's trading session at $0.01365, up 33.77%, on 10,000 volume with 1 trades. The average volume for the last 3 months is 16,095 and the stock's 52-week low/high is $0.002/$0.044.

chart

Fiore Gold Ltd. (FIOGF)

Investors Hangout, OTC Markets, MarketWatch, TradingView, Investorx, Stockhouse, Stockwatch, Wallet Investor, GuruFocus, Energy and Gold, Stock Orange, Barchart, Dividend Investor, The StreetWise Reports, Market Screener, WatchDog Stocks, Pinnacle Digest, The Street, and Morningstar reported previously on Fiore Gold Ltd. (FIOGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer listed on the OTC Markets Group’s OTCQB. The Company has the producing Pan Mine in Nevada. In addition, it has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado.

Fiore Gold’s primary goal is to build a new mid-tier mining company in the world’s top mining jurisdictions. The Company’s initial aim is on becoming an 150,000-ounce/year gold producer. Pertaining to North American Projects, Fiore Gold’s assets include the producing Pan Mine near Eureka, Nevada. Assets also include the nearby Gold Rock exploration project. Furthermore, Fiore Gold controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. Pan comprises three main zones of mineralization that has now been traced for greater than 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton). The Company previously announced the start of exploration drilling at its Pan Mine, as part of a longer-term program intended to expand the resource and reserve base at Pan.

Concerning South American Properties, Fiore has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property consists of 13 mining claims totaling 3,400 hectares. It is about 130 kilometers southeast of Antofagasta, Chile.

The Cerro Tostado (South America) project comprises five concessions totaling approximately1,500 ha located in Region II roughly 125 km southeast of Antofagasta. The Rio Loa property is in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is about 25 km south of Salares Norte.

This past December, Fiore Gold announced an updated resource estimate for its Pan open pit mine in White Pine County, Nevada following the completion of the 2018 resource expansion drilling program. The updated resource estimate includes Measured and Indicated (M+I) resources of 27.6 million tonnes grading 0.49 g/t containing 432,000 ounces of gold and Inferred Resources of 7.6 million tonnes grading 0.45 g/t containing 110,000 ounces of gold. The updated resource estimate has resulted in almost total replacement of roughly 19 months of mining depletion in the M+I category, and the addition (net of depletion) of roughly 38,000 gold ounces in the Inferred category.

Last week, Fiore Gold announced that its financial statements and management's discussion and analysis for the first fiscal quarter (Q1 2019) ended December 31, 2018, were filed with the securities regulatory authorities. For Q1 2019, the Company had Gold production of 9,765 ounces. This represents a 47 percent increase over Q1 2018. It had Gold sales of 9,744 ounces at an average realized price of $1,232 per ounce.

Fiore had Q1 2019 Pan Mine AISC (all-in sustaining costs) per ounce sold of $882 and cash costs per ounce sold of $812, versus Q1 2018 Pan Mine AISC per ounce sold of $1,704 and cash costs per ounce sold of $822. Q1 2019 Fiore consolidated AISC was $995 versus Q1 2018 Fiore consolidated AISC of $1,900.

Fiore Gold Ltd. (FIOGF), closed Friday's trading session at $0.258, up 8.49%, on 48,500 volume with 11 trades. The average volume for the last 3 months is 55,012 and the stock's 52-week low/high is $0.157/$0.562.

chart

Freddie Mac (FMCKL)

Penny Stock Tweets, 4-Traders, Interactive Brokers, OTC Markets, Pink Investing, stockcharting.tips, Wallmine, MarketWatch, Nasdaq, Stockhouse, moneyhub, GuruFocus, Investors Hangout, InvestorsHub, Trading View, Barchart, and Seeking Alpha reported earlier on Freddie Mac (FMCKL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freddie Mac operates in the secondary mortgage market in the U.S. It buys residential mortgage loans originated by lenders, and also invests in mortgage loans and mortgage-related securities. Freddie Mac supports the housing market and the nation’s renters, homebuyers and homeowners throughout the entire nation and in all economic cycles. The Company is headquartered in McLean, Virginia and was chartered by Congress in 1970.

Freddie Mac operates by way of three business lines. These comprise Single-Family, Multifamily, and Capital Markets. The Company’s Single-Family business supports responsible, sustainable homeownership. Freddie Mac works with lenders of all sizes - national, regional, and community lenders and credit unions - to purchase conventional, conforming mortgage loans for one- to four-unit homes (including condominiums and manufactured homes) up to a certain dollar amount set by the Company’s regulator.

Freddie Mac Multifamily (working with a network of specialized vendors) provides funding for loans on properties ranging from five units to hundreds of units across manifold buildings. Moreover, the Company’s Capital Markets business promotes the mortgage market’s liquidity. It makes funding more available to borrowers through buying mortgage-related securities guaranteed by Freddie Mac and other financial institutions as investments and managing its portfolio.

Because it operates in the U.S. secondary mortgage market, Freddie Mac doesn’t lend directly to borrowers. The Company purchases loans that meet its standards from approved lenders. With the money that lenders receive in return, they can make loans to other qualified borrowers. In securitizing pools of mortgages and selling the securities to investors, Freddie Mac shifts a major portion of the credit risk associated with the loans it owns to private investors – away from taxpayers.

The Wall Street Journal reported this week that Freddie Mac is providing financing for a portfolio of over 300 rental homes under a now-defunct pilot program intended to help address the shortage of homes for middle-class families. The close to $26 million pact with Atlanta-based Promise Homes provides financing for these 300 affordable rental homes.

Freddie Mac (FMCKL), closed Friday's trading session at $7.45, down 1.46%, on 33,700 volume with 25 trades. The average volume for the last 3 months is 66,456 and the stock's 52-week low/high is $4.45/$9.00.

chart

Innovation Pharmaceuticals, Inc. (IPIX)

Streetwise Reports, Tip Ranks, Insider Financial, Stockopedia, InvestorsHub, Emerging Growth, Stockdigest Report, MarketWatch, Real Investment Advice, Simply Wall St, Stockhouse, The OTC Reporter, Wallet Investor, Investors Hangout, and Barchart reported earlier on Innovation Pharmaceuticals, Inc. (IPIX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Innovation Pharmaceuticals, Inc. is an OTCQB-listed clinical stage biopharmaceutical company. It is developing unique therapies in manifold diseases. Its belief is that it has a premier portfolio of first-in-class lead drug candidates. The Company is presently advancing them toward market approval, while seeking strategic partnerships. Innovation Pharmaceuticals is headquartered in Beverly, Massachusetts. Innovation is establishing a wholly-owned European subsidiary for the purpose of the development of its drug candidates globally.

The Company’s anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. Innovation Pharmaceuticals commenced a Phase 2 study in Ovarian Cancer.

Innovation has its Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Brilacidin - a defensin mimetic compound - has shown in an animal model to reduce the occurrence of severe ulcerative Oral Mucositis (OM) by greater than 94 percent versus placebo.

Brilacidin completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin.

The Company’s Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and Innovation launched a Phase 2b study. Prurisol is a small molecule. It acts via immune modulation and PRINS reduction.
This past December, Innovation Pharmaceuticals announced that the Company and the U.S. Food and Drug Administration (FDA) completed an End-of-Phase 2 meeting regarding the continuing development of Brilacidin oral rinse to reduce the incidence of Severe Oral Mucositis (SOM) in Head and Neck Cancer (HNC) patients receiving chemoradiation. Brilacidin oral rinse is undergoing development under FDA Fast Track designation for Oral Mucositis (OM).

Both parties agreed to an acceptable Brilacidin Phase 3 development pathway. This includes studying Brilacidin oral rinse effects on SOM when cisplatin is administered in higher concentrations (80-100 mg/m2) every 21 days, and at lower concentrations (30-40 mg/m2) administered weekly as part of the  chemoradiation regimen.

Recently, Innovation Pharmaceuticals announced plans to initiate this year a clinical trial of Brilacidin as an oral dosage form. Building upon the successful Phase 2 Proof-of-Concept (PoC) clinical trial for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), the goal of the program is to develop treatment for the more extensive forms of Inflammatory Bowel Disease (IBD), such as Ulcerative Colitis and Crohn’s Disease.

Last week, Innovation Pharmaceuticals announced that the Companies Registration Office Ireland provided notification that Innovation’s subsidiary, IPIX Pharma Limited, is registered under the Companies Act 2014, effective February 15, 2019. As Innovation will now be engaging the European Medicines Agency (EMA) to advance its clinical pipeline, the benefits of the subsidiary to the Company will be immediate.

Innovation Pharmaceuticals, Inc. (IPIX), closed Friday's trading session at $0.1255, up 0.40%, on 219,203 volume with 44 trades. The average volume for the last 3 months is 495,690 and the stock's 52-week low/high is $0.07/$0.695.

chart

Leading Edge Materials Corp. (LEMIF)

InvestorsHub, MarketWatch, Stockhouse, Metals Channel, 4-Traders, Investing News, Penny Stock Tweets, Wall Street Analyzer, Metals News, Market Screener, and Investor Place reported earlier on Leading Edge Materials Corp. (LEMIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Leading Edge Materials Corp. concentrates on the production of high value critical raw materials for the European market. It has an operating base in the Nordic region. The Company’s flagship asset is the Woxna Graphite production facility in central Sweden targeting the supply of specialty materials for lithium ion battery production. OTCQB-listed, Leading Edge Materials is based in Vancouver, British Columbia.

The Company operates in four divisions: Graphite, Lithium, Rare Earth and Cobalt. Leading Edge’s assets and research focus are towards the raw materials for Li-ion batteries (graphite, lithium, cobalt); materials for high thermal efficiency building products (graphite, silica, nepheline); and materials that improve the efficiency of energy generation (dysprosium, neodymium, hafnium). Its investments are linked to the global shift to low-carbon energy generation and energy storage.

Leading Edge Materials has 100 percent ownership of industry-leading assets in the Nordic region. It has 100 percent ownership of graphite, cobalt, lithium and rare earth element deposits across three mining supportive jurisdictions. In addition, the Company has a unique position in the sustainable supply of critical materials for the high growth lithium ion battery market.

Leading Edge Materials has its Romanian Exploration Alliance. The Exploration Alliance is focused on the discovery and development of lithium ion battery raw materials. The main efforts of the Exploration Alliance as of early November 2018, was directed towards cobalt mineralization within the Upper Cretaceous Carpathian magmatic belt of the Balkan region.

In January, Leading Edge Materials provided a summary of test work conducted on graphite from its 100 percent owned Woxna mine in Sweden during last year. With the test program complete, the Company is now moving ahead to an engineering study supporting the installation of a Battery Graphite Demonstration Plant at the Woxna site. The demonstration plant, when installed, will enable process conditions to be optimized and larger volumes of natural graphite anode material to be supplied to prospective lithium ion battery customers.

Leading Edge Materials is advancing a portfolio of European battery raw material projects. These include the fully built and permitted above-mentioned Woxna graphite mine in Sweden, the Bihor Sud cobalt-copper-nickel project in Romania, and the Norra Kärr heavy rare earth element-zirconium-hafnium deposit. All are high merit projects within the European raw material sector.

The Company’s internal corporate Strategic Review firstly highlighted that Leading Edge's combination of discovery-stage and development-stage assets may present different requirements concerning operational structure, capital needs and investor preferences. The Board resolved that the next stage of the Strategic Review will identify and compare opportunities for the Woxna graphite mine.

Potential recommendations from this stage of the Strategic Review may include a transition to a freestanding European company. Additionally, it will consider direct third-party investment into Woxna, horizontal or vertical joint-venture of with aligned parties, or a standalone public listing of Woxna on a Swedish exchange. The Board cautions that there is no assurance or guarantee that any potential transaction identified by the Strategic Review will be pursued.

Leading Edge Materials Corp. (LEMIF), closed Friday's trading session at $0.137, down 10.34%, on 28,450 volume with 7 trades. The average volume for the last 3 months is 74,096 and the stock's 52-week low/high is $0.1085/$0.6399.

chart

Sun BioPharma, Inc. (SNBP)

Ahead of the Bulls, All Penny Stocks, The Stock Wizards, The Dean, FeedBlitz, Microcap Voice, Hot Shot Stocks, Wall Street Resources, Lebed, Today's Financial News, Hot Penny Stocks Now, OTC Picks, Beacon Equity Research, Greenbackers, CoolPennyStocks, Otcstockexchange, and HotOTC reported previously on Sun BioPharma, Inc. (SNBP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sun BioPharma, Inc. is a Biopharmaceutical Company listed on the OTCQB. It is developing disruptive therapeutics for the treatment of patients with pancreatic diseases. A clinical-stage biopharmaceutical enterprise, Sun BioPharma’s development programs target diseases of the pancreas. This includes pancreatic cancer and pancreatitis. Sun BioPharma has its corporate office in Waconia, Minnesota.

The Company has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, California; the University of Miami; the University of Florida; the Mayo Clinic Scottsdale; the Austin Health Cancer Trials Centre and the Box Hill Hospital in Melbourne, Australia, and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma’s first product candidate is SBP-101. This product is for the treatment of patients with pancreatic cancer. Mr. Ray Bergeron, Ph.D. Distinguished Professor Emeritus, University of Florida invented SBP-101.The Company’s plan is to develop SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma, the most common kind of pancreatic cancer.

SBP-101 is a first-in-class, proprietary, polyamine compound. The design of it is to exert therapeutic effects in a mechanism specific to the pancreas. In 2011, Sun BioPharma originally licensed SBP-101 from the University of Florida.

The Company’s SBP-102 is currently in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. In addition, its SBP-103 is currently in non-clinical exploratory evaluation.

On November 1, 2018, Sun BioPharma presented results of a new study entitled “Effect of SBP-101 in a Mouse Model of Cerulein-induced Acute Pancreatitis” at the American Pancreatic Association meeting in Miami, Florida that day. The study, performed in collaboration with Cedars-Sinai Medical Center in Los Angeles, California and funded by the National Institutes of Health, evaluated the ability of SBP-101, a polyamine metabolic inhibitor (PMI), to impact the development of acute pancreatitis using different formulations and dosing regimens.

Michael Walker, MD, Director of Pancreatic Research at Sun BioPharma and one of the study’s co-Principal Investigators, said then “In some instances, administration of SBP-101 was able to decrease levels of amylase and lipase, markers of acute pancreatitis in the blood, and reduce swelling and inflammation in the pancreas.”

Sun BioPharma, Inc. (SNBP), closed Friday's trading session at $2.65, down 18.46%, on 300 volume with 1 trade. The average volume for the last 3 months is 218 and the stock's 52-week low/high is $2.05/$15.00.

chart

K92 Mining, Inc. (KNTNF)

Future Money Trends, TradeKing, Investors Hangout, GuruFocus, Marketwired, Stockhouse, MarketWatch, InvestorsHub, Barchart, OTC Markets, Morningstar, and Resource Stock Digest reported earlier on K92 Mining, Inc. (KNTNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

K92 Mining, Inc. engages in the exploration and development of mineral deposits in Papua New Guinea. It has commenced gold production from the Irumafimpa Gold Deposit that together with the Kora Gold Deposit is part of its Project located in the Eastern Highlands province of Papua New Guinea. K92 Mining is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQX.

Kainantu highlights include existing infrastructure. This includes underground mine development, a mill processing facility, staff housing, a licensed tailings pond, office space, paved access roads, and a reliable hydro supply through a dedicated power line. The Kainantu property covers a total area of around 410km2.

In addition, Kainantu highlights include USD $41.3 million invested in exploration drilling and definition drilling. The current resource estimate is based on 78,935m of drilling through 767 drill holes.

The Process Mill previously successfully treated the first batch of underground ore delivered from Irumafimpa, with concentrate now produced. There is a major opportunity to expand known zones of mineralization, and for the discovery of new ore bodies. K92 Mining attained and declared commercial production, effective February 1, 2018, at its Kainantu Gold Mine in Papua New Guinea.

This past August, K92 Mining announced an updated resource for Kora North. The updated resource for Kora North consists of a Measured Resource of 242,900 tonnes @ 13.9 g/t Au, 19 g/t Ag and 1.0% Cu; an Indicated Resource of 442,800 tonnes @ 11.8 g/t Au, 21 g/t Ag and 1.2% Cu; and an Inferred Resource of 1,084,400 tonnes @ 13.6 g/t Au, 15 g/t Ag and 1.0% Cu. Exploration drilling began on the Yanobo/Yompassa porphyry target.

During Q2 2018, K92 Mining produced 10,485 ounces of gold, 128,634 pounds of copper and 1,671 ozs of silver or 10,800 AuEq ozs (based on a Gold price of US$1,300/oz; Silver US$16.5/oz; Copper US$2.90/lb). Furthermore, in Q2, the Company’s mining operations centered on Kora North at its Kainantu Gold Mine in Papua New Guinea. Kora remains open for expansion in every direction and strongly mineralized at the extent of all drilling.

K92 Mining, Inc. (KNTNF), closed Friday's trading session at $1.02, up 4.08%, on 182,162 volume with 137 trades. The average volume for the last 3 months is 106,053 and the stock's 52-week low/high is $0.432/$1.03.

chart

GH Capital, Inc. (GHHC)

Penny Picks, OTC Markets, MarketWatch, Barchart, Stockopedia, Morningstar, and InvestorsHub reported on GH Capital, Inc. (GHHC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

GH Capital, Inc. has developed an online payment gateway (ClickDirectPay) to process online wire transfer transactions for different online merchants, chiefly in Europe. GH Capital is a FinTech holding company and offers a going public process advisory. Formed in 2014, GH Capital has its head office in Miami, Florida. The Company lists OTC Markets’ OTCQB.

GH Capital’s Financial Technology (FinTech) product is ClickDirectPay.com.
Customers using ClickDirectPay can do a bank transfer fast, easily, as well as securely with their personal online banking information. Upon using ClickDirectPay, the merchant receives a real time transaction confirmation pertaining to the successful bank transfer.

GH Capital’s goal is to expand with ClickDirectPay worldwide. To meet this objective, it is working on concepts of Blockchain and Cryptocurrency processing.

Regarding the Company’s Capital Market Advisory Service, it guides and assists international companies from the U.S, Canada, Europe, and Asia to complete the whole going public process from the beginning. GH Capital’s mission is to help small and emerging growth companies to get through the complete IPO (Initial Public Offering) process without difficulties.

GH Capital is also considering acquisitions. The Company stated that 2018 could also be a year of acquiring companies from the payment industry. This could speed up the process to establish ClickDirectPay as a one stop solution for Cryptocurrency processing.

Recently, GH Capital announced that its online payment service subsidiary, ClickDirectPay, announced the launch of ClickDirectPay's Express Coin Payments. This provides merchants the ability to accept many cryptocurrencies into a secure wallet.

In May, GH Capital announced that its online payment service subsidiary, ClickDirectPay expanded its cryptocurrency payment solution offerings to support Monero, Dash, Zcash and Verge. The addition of these coins brings the total support of ClickDirectPay to 8 cryptocurrencies enabling businesses to scale their reach in accepting payments in the world of cryptocurrencies.

ClickDirectPay is introducing new tools for merchants to easily start accepting cryptocurrencies. In June, the Company announced that its online payment service subsidiary, ClickDirectPay rolled-out new tools to its online merchants to be able to more easily and quickly accept cryptocurrency as payment.

GH Capital, Inc. (GHHC), closed Friday's trading session at $0.016, up 6.67%, on 9,279,996 volume with 229 trades. The average volume for the last 3 months is 9,566,023 and the stock's 52-week low/high is $0.0029/$0.40.

chart

Blue Eagle Lithium, Inc. (BEAG)

Stockwatch, Wallstreet Online, InvestorsHangout, Barchart, Financial Buzz, Simply Wall St, TradingView, MarketWatch and last10k reported on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blue Eagle Lithium, Inc. is a lithium exploration and development company. It engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The Company previously went by the name Wishbone Pet Products, Inc. It changed its name to Blue Eagle Lithium, Inc. last month. The Company has its corporate office in Henderson, Nevada. Blue Eagle Lithium lists on the OTC Markets Group’s OTCQB.

Blue Eagle Lithium has a 100 percent Working Interest (WI) in 200 placer claims in Railroad Valley, Nevada, a highly prospective green-fields lithium brine target in the heart of the Basin and Range geologic province. The staked claims encompass 4,000 acres (roughly 1,619 hectares) over a large portion of Railroad Valley. They are ready for the next phase of lithium exploration.

The Railroad Property is approximately 48 miles to the southwest of Ely, Nevada. Railroad Valley, Nevada is a highly prospective green-fields Petro-Lithium brine target area. It features many similarities to the nearby Clayton Valley.

The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Test wells will be drilled to provide lithologic data and lithium analysis samples.

The Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on different sources of geological data. Blue Eagle Lithium’s team will analyze available samples, well logs and seismic data to complete the geologic picture for the Railroad Property in light of present lithium brine-formation theories.

Blue Eagle Lithium’s core leadership team consists of experienced leaders whom represent many years of industry experience in the energy, financial, and geology fields. This core team comprises Mr. Rupert Ireland: CEO, Board of Directors; Mr. Rod Murray: Chief Operations Officer (COO); Mr. Gavin Harrison: Director of Operations; and Mr. Robert FE Jones: Board Advisor.

Blue Eagle Lithium, Inc. (BEAG), closed Friday's trading session at $0.81, up 1.50%, on 5,855 volume with 9 trades. The average volume for the last 3 months is 12,548 and the stock's 52-week low/high is $0.079/$3.50.

chart

Dthera Sciences (DTHR)

4-Traders, OTC Markets, MarketWatch, Investors Hub, Barchart, Stockopedia, TradingView, and Simply Wall St reported on Dthera Sciences (DTHR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Dthera Sciences is a digital therapeutics company listed on the OTC Markets’ OTCQB. The Company works to improve Quality of Life (QoL) and lessen anxiety in residents with Alzheimer’s, Dementia, and isolation. Its concentration is on developing innovative digital QoL therapies for neurodegenerative diseases and oncology. Dthera Sciences’ lead product is ReminX (regarding Reminiscence Therapy for Anxiety Reduction). Dthera Sciences has its headquarters in San Diego, California.

ReminX is an artificial-intelligence (AI)-powered digital therapeutic. The design of ReminX is to lessen anxiety and improve QoL in patients with Alzheimer's disease and Dementia. ReminX has completed a successful clinical trial with the University of California San Diego showing its effectiveness as a scalable form of Reminiscence Therapy.

Reminiscence Therapy (RT) is talking about or reviewing recognizable memories. This is through looking at photos, and hearing or discussing the familiar stories related to them. ReminX is a digital therapeutic. It takes personalized stories and delivers a treatment called Reminiscence Therapy to ease stress.

Family members use the ReminX application (app) to upload photos and provide narration. Seniors pick up their ReminX tablet to watch stories from their own and their loved one’s lives. The patient’s custom tablet plays stories on demand. There is no interface for the patient to learn. Picking up the tablet starts stories. Putting the tablet down stops them. ReminX utilizes a digital assistant to help in curating content for an individual’s loved one. ReminX is available on IOS and Android.

Important developments for Dthera Sciences in 2017 included completing a proof-of-concept study for lead product, ReminX, at University of California San Diego. Study results in 14 patients suffering from dementia showed considerable decreases in anxiety, depression, and overall emotional distress. Moreover, the Company completed a successful beta test of its proprietary sales funnel, providing key proof points in support of achieving 2018 sales targets for ReminX.

Recently, Dthera Sciences announced the launch of ReminX™. This is an AI-powered consumer health product. The design of it is to digitally deliver Reminiscence Therapy to individuals suffering from Alzheimer's and other dementias, and also from social isolation. This digital therapeutic device is the first to center on the care of the elderly.

Mr. Edward Cox, Dthera Sciences’ Chief Executive Officer, said, "For the first time, hyper-personal Reminiscence Therapy can be delivered to thousands of individuals for a little over a dollar a day. This is a great example of compelling science and scalable technology being combined to make a major positive impact."

Last week, Dthera Sciences announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to Dthera’s development-stage product, DTHR-ALZ. If granted approval, DTHR-ALZ would become the first non-pharmacological prescription treatment for the symptoms of Alzheimer's disease. The intention of DTHR-ALZ is to be a prescription digital therapeutic that will deliver Reminiscence Therapy to patients with Alzheimer's disease. The device will use AI to automatically optimize the therapy based on different forms of biofeedback from the patient.

The proposed indication for use states that "DTHR-ALZ is intended to mitigate the symptoms of agitation and depression associated with major neurocognitive disorder of the Alzheimer's type." To the Company's knowledge, Dthera is only the second digital therapeutics company to achieve Breakthrough Device designation from the FDA.

Dthera Sciences (DTHR), closed Friday's trading session at $6.00, up 18.81%, on 215 volume with 2 trades. The average volume for the last 3 months is 339 and the stock's 52-week low/high is $2.95/$16.79.

chart

Nemaura Medical, Inc. (NMRD)

Market Exclusive, BusinessWire, Barchart, OTC Markets, InvestorsHub, Stockhouse, Simply Wall St, and 4-Traders reported on Nemaura Medical, Inc. (NMRD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nemaura Medical, Inc. is a medical technology business developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, pain-free, and affordable continuous glucose monitoring (CGM) system for adjunctive use by diabetics. The Company’s patient-friendly technology has the potential to transform health monitoring through providing real-time, tailored feedback on glucose, lactate, and other vital body performance metrics. Listed on the NasdaqCM, Nemaura Medical is headquartered in Loughborough, England.

Nemaura’s patented BEAT™ technology (passing a mild, non-perceptible electric current across the skin) draws a small number of selected molecules, such as glucose, into a patch placed on the skin. These molecules are drawn out of the interstitial fluid. The patch (via a sensor) measures the amount of that molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment.

The BEAT™ technology will permit remote continuous monitoring of chronic diseases and health conditions. It is to replace traditional invasive methods of diagnosis and healthcare observation procedures. The sugarBEAT® App can be pre-downloaded on a user’s smart device. There is an optional sugarBEAT® handheld reader (applicable where a user chooses not to use their own smart device).

sugarBEAT® provides accurate glucose measurement.  sugarBEAT® consists of a reusable transmitter containing a daily-disposable adhesive skin-patch.

At the end of July, Nemaura Medical announced it started the first of several planned studies in support of a submission to the U.S Food & Drug Administration (FDA) for approval of its sugarBEAT® product. The Company further announced positive interim results from the home-use portion of this initial study.

The expectation is that the initial U.S. study will enroll 75 patients wearing the device over a 7-day period, including 3 days in a clinical setting (525 total patient days; 225 total in-clinic days). Initial U.S. study completion and FDA submission is anticipated in Q1 2019.

With its approved contract manufacturers, Nemaura Medical started manufacturing scale-up in preparation for expected launch in the United Kingdom (UK) in the coming months. The Company placed an initial order with a UK contract manufacturer for 12,500 sugarBEAT® rechargeable transmitters. These will be supplemented with about 100,000 skin-patches per month.

Nemaura Medical, Inc. (NMRD), closed Friday's trading session at $1.08, up 4.85%, on 100,987 volume with 133 trades. The average volume for the last 3 months is 149,368 and the stock's 52-week low/high is $0.80/$5.46.

chart

Asaleo Care Limited (ASLEF)

Penny Stock Tweets, The Street, Trade Ideas, Current Charts, Market Screener, TradingView, OTC Markets, Morningstar, Barchart, 4-Traders, Dividend Investor, Stockhouse, GuruFocus, MarketWatch, YCharts, Wallmine, Capital Cube and Wallet Investor reported on Asaleo Care Limited (ASLEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Asaleo Care Limited is a foremost personal care and hygiene Company listed on the OTC Markets. It manufactures, markets, distributes and sells essential everyday consumer products. These products encompass the Feminine Care, Incontinence Care, Baby Care, Consumer Tissue and Professional Hygiene product categories.

Established in 1932, Asaleo Care has its corporate headquarters in Box Hill, Australia. The Company previously went by the name PEPSCA Limited. It changed its name to Asaleo Care Limited in May of 2014.

Asaleo Care is organized into three business units. These units are Consumer Tissue, Personal Care and Professional Hygiene. By way of its Consumer Tissue division, the Company manufactures and markets several top consumer brands. These include Sorbent toilet and facial tissue, Handee paper towel, Deeko disposable tableware, Purex toilet tissue as well as Treasures nappies (New Zealand only).

Via its Personal Care division, Asaleo Care manufactures and markets leading personal hygiene products under the Libra feminine hygiene brand and the TENA incontinence brand. The Company’s Professional Hygiene business delivers Tork hygiene solutions to the commercial, public, health care, food service and industrial segments.

Asaleo Care supplies dispensers, paper towels, toilet tissue, soaps, napkins and industrial and kitchen wipers under the international Tork brand. The majority of the Company’s brands hold number 1 or 2 market positions in Australia and New Zealand.

In addition, Asaleo Care has its Pacific Islands initiative. The Company is well represented in the Pacific Islands through the distribution of a broad set of Consumer Tissue, Tork Professional Hygiene and Personal Care products. It is also well represented through the presence of a manufacturing site near Suva in Fiji.

The Fijian plant produces toilet rolls, kitchen towels, serviettes, as well as facial tissues. The local brands Orchid and Viti are well known. These brands have market leadership in the Pacific Islands region.

Asaleo Care Limited (ASLEF), closed Friday's trading session at $0.67, up 2.29%, on 10,400 volume with 1 trade. The average volume for the last 3 months is 8,562 and the stock's 52-week low/high is $0.45/$1.10.

chart

Kraken Robotics, Inc. (KRKNF)

OTC Markets, 4-Traders, Barchart, Morningstar, Stockhouse, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics, Inc.’s commitment is to the production and sale of software, sensors, and robotic systems for the global Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. A marine technology company, Kraken Robotics is based in St. John’s, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia.

Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products named AquaPix® leverages almost 20 years of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a reduced cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). Additionally, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Kraken Robotics has expanded from sensors to complete systems. The Company has introduced its KATFISH™ tethered underwater vehicle. Kraken has also introduced the THUNDERFISH® autonomous underwater vehicle (AUV). Furthermore, Kraken has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology. This product is for the oil and gas sector for ROVs.

Kraken also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

In addition, Kraken has its DataPod™ product. The design of it is to meet contemporary data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid-state storage all in one compact unit.

Kraken Robotics’ wholly-owned subsidiary, Kraken Robotic Systems, Inc., is developing an ultra-wideband acoustic remote sensing system for seafloor imaging and mapping. The AquaPix® Multispectral Synthetic Aperture Sonar (SAS) will be the world’s first commercial SAS to operate over such a wide spectrum, ranging from low audible frequencies to high ultrasonic frequencies.

Last week, Kraken Robotics announced that Kraken Robotic Systems, Inc. signed a Cooperative Research and Development Agreement (CRADA) with the Office of Ocean Exploration and Research (OER) of the National Oceanic and Atmospheric Administration (NOAA). The data and information OER collect can be used to improve ocean research, inform policy and management decisions, develop new lines of scientific inquiry, and advise NOAA and the United States on vital issues.

Mr. Karl Kenny, Kraken Robotics’ President and Chief Executive Officer, said, “We feel this will be a truly symbiotic relationship between NOAA OER and Kraken by combining their real-time, global data transfer capabilities with our real-time processing incorporated to all of our sensors, allowing for high-resolution laser and sonar data to travel from the seafloor to researchers around the world at an unprecedented rate.”

Kraken Robotics, Inc. (KRKNF), closed Friday's trading session at $0.510064, down 1.13%, on 23,372 volume with 22 trades. The average volume for the last 3 months is 50,863 and the stock's 52-week low/high is $0.10644/$0.5799.

chart

The QualityStocks Company Corner

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Dynamic plant-based food and beverage company Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company, Headset, Inc., formed a landmark strategic alliance with Nielsen Holdings plc (NYSE: NLSN). To view the full press release, visit: http://nnw.fm/vAfd7.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.48, up 2.28%, on 464,873 volume with 905 trades. The average volume for the last 3 months is 590,508 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or "the Company") today announced issuance of shares of common stock for completed consulting services with JDS 4300 Consulting LLC ("JDS") and TSB Consulting LLC ("TSB") for arm's length previously-rendered strategic corporate advisory and corporate structure and reorganization services, respectively. Also today, the company was highlighted in an article examining how the marijuana stock market has been fueled heavily with companies working to produce greater yields of cannabis over the course of the past few months.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.65, up 5.19%, on 180,697 volume with 370 trades. The average volume for the last 3 months is 211,158 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication looking at some of the top plays in the cannabis market.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.18, up 0.14%, on 1,164,084 volume with 1,482 trades. The average volume for the last 3 months is 1,145,906 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

In an interview on MoneyTV with Donald Baillargeon, ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang noted his intention, within three to five years, for the company to uplist to the New York Stock Exchange or Nasdaq Small Cap Market as it reaches up to $10 million in annual volume (http://nnw.fm/7hveB).

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.4698, up 1.30%, on 26,321 volume with 18 trades. The average volume for the last 3 months is 86,201 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services (OTCQB: SHRV), a Plano, Texas-based diversified holding company, employs an interesting business model that concentrates on mentorship of subsidiary companies. To view the full article, visit: http://nnw.fm/vmAM4.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.24, up 4.35%, on 7,300 volume with 2 trades. The average volume for the last 3 months is 42,943 and the stock's 52-week low/high is $0.17/$0.55.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Black Iron (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron-ore exploration and development company, holds an ideal position amid recent supply shortages and the subsequent tension in the global iron ore market. To view the full article, visit: http://nnw.fm/02iY0.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0569, up 5.37%, on 510,269 volume with 53 trades. The average volume for the last 3 months is 1,362,003 and the stock's 52-week low/high is $0.05/$0.259.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) CEO Greg Lambrecht was featured today on MoneyTV with Donald Baillargeon, where he announced a major acquisition.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01933, up 2.55%, on 2,597,303 volume with 108 trades. The average volume for the last 3 months is 6,154,081 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright (TSX.V: THRM) (OTC: THRBF) is focused on protecting the human body’s largest and fastest-growing organ, skin, which is a vital guard against damage to all other organs. To view the full article, visit: http://nnw.fm/lMs6K.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0278, even for the day, on 26,000 volume. The average volume for the last 3 months is 6,571 and the stock's 52-week low/high is $0.0098/$0.0289.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, is building a robust portfolio of investments and joint ventures that operate within the legal cannabis and industrial hemp markets. To view the full article, visit: http://nnw.fm/UdY1n.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0121, even for the day, on 6,042,129 volume with 265 trades. The average volume for the last 3 months is 13,695,988 and the stock's 52-week low/high is $0.0115/$0.0498.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Leading California edibles manufacturer Plus Products (CSE: PLUS) (OTCQB: PLPRF) this morning announced that it has secured eligibility by The Depository Trust Company (“DTC”) for its shares on the OTC. To view the full press release, visit: http://nnw.fm/w314G.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $6.05, off by 3.20%, on 45,733 volume with 96 trades. The stock's 52-week low/high is $2.809/$6.008.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that the Company has appointed Mr. Nikhil Handa as the Company's new Chief Financial Officer. Current Chief Financial Officer, Dimitre Naoumov, will become the Company's Vice President, Finance. Also today, CannabisNewsWire released a report on the company detailing how SPRWF continues to build on its reputation as a global organization that produces and distributes consumer-centric, proprietary cannabis plant products. The company’s mission, aptly stated in an investor presentation (http://cnw.fm/94G9y), is to “make a positive impact on people and the planet by continuing to grow better cannabis businesses globally.” Additionally, SPRWF was featured today in the 420 with CNW by CannabisNewsWire.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.54, off by 1.91%, on 1,085,917 volume with 1,657 trades. The average volume for the last 3 months is 508,983 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron-ore exploration and development company, holds an ideal position amid recent supply shortages and the subsequent tension in the global iron ore market. To view the full article, visit: http://nnw.fm/02iY0.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0495, up 6.45%, on 950 volume with 2 trades. The average volume for the last 3 months is 37,887 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

End-to-end telecommunications network service provider Spectrum Global Solutions Inc. (OTCQB: SGSI) is positioned to enable the buildup of 5G networks as providers — including some major SGSI clients such as multinational telecommunications giants Sprint, AT&T and Verizon — rollout their options for service that’s expected to be 10- to 100-times faster than current coverage. SGSI’s subsidiaries, AW Solutions, ADEX Corp., TNS Inc. and Tropical Communications, serve the company’s array of carrier, aggregator, utility, enterprise, project management organization (“PMO”) and original equipment manufacturer (“OEM”) clients across the United States, Canada, Puerto Rico, Guam and the Caribbean.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.2575, off by 4.59%, on 805,078 volume with 309 trades. The average volume for the last 3 months is 76,176 and the stock's 52-week low/high is $0.071/$2.59.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Growing Demand for Nickel for Batteries Drives Increased Investments in Indonesian Nickel Sector," featuring Pacific Rim Cobalt Corporation (OTCQB: PCRCF) (CSE: BOLT). To hear the NetworkNewsAudio version, visit: http://nnw.fm/Io88C. To read the full editorial, visit: http://nnw.fm/W474y.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.1403, off by 18.67%, on 141,239 volume with 29 trades. The average volume for the last 3 months is 25,437 and the stock's 52-week low/high is $0.0701/$0.568.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.